Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases

Genes Chromosomes and Cancer

Volumn 33, Issue 2, 2002, Pages 141-149

  Rodriguez, Carmen ^a   Vallès, Hélène ^a   Causse, Annick ^a   Johannsdottir, Vala ^a   Eliaou, Jean François ^b   Theillet, Charles ^a,c  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^b HÔPITAL SAINT ELOI   (France)

^c INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN;

ALLELISM; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CHROMOSOME 11Q; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; GENE DELETION; GENE INACTIVATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PRIORITY JOURNAL; SOMATIC MUTATION; TELOMERE;

ALLELES; ATAXIA TELANGIECTASIA; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS; VARIATION (GENETICS);

EID: 0036141330     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.1222     Document Type: Article

References (37)

1. No evidence for constitutional ATM mutation in breast/gastric cancer families
2. Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer
3. Breast cancer and other cancers in Norwegian families with ataxiatelangiectasia
4. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility
5. The role of ATM in DNA damage responses and cancer
6. Loss of heterozygosity at 11q22q23 in breast cancer
7. New mutations, polymorphisms, and rare variants in the ATM gene detected by a novel SSCP strategy
8. The role of ataxia-telangiectasia heterozygotes in familial breast cancer
9. ATM heterozygosity and breast cancer: Screening of 37 breast cancer patients for ATM mutations using a non-isotopic RNase cleavage-based assay
10. Cancer risks in A-T heterozygotes
11. Heterozygous ATM mutations do not contribute to early onset of breast cancer
12. Cancer risk in ATM heterozygotes: A model of phenotypic and mechanistic differences between missense and truncating mutations
13. Cancer risk in heterozygotes for ataxia-telangiectasia
14. Loss of heterozygosity in sporadic human breast carcinoma: A common region between 11q22 and 11q23.3
15. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia
16. Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer
17. Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia. Cowden disease and BRCA1 gene regions
18. Mutation and cancer: Statistical study of retinoblastoma
19. Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study
20. Screening breast cancer patients for Norwegian ATM mutations
21. Disruption of the ATM gene in breast cancer
22. p53 Mutations occur in aggressive breast cancer
23. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: Identification of a new region at 11q23.3
24. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain
25. Ataxia-telangiectasia locus: Sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene
26. At least five regions of imbalance on 6q in breast tumors, combining losses and gains
27. ATM: From gene to function
28. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: Expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer
29. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia
30. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia
31. Inactivation of the ATM gene in T-cell prolymphocytic leukemias
32. Incidence of cancer in 161 families affected by ataxia-telangiectasia
33. ATM mutations in cancer families
34. The ATM gene and susceptibility to breast cancer: Analysis of 38 breast tumors reveals no evidence for mutation
35. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia
36. Cancer. New link in a web of human genes
37. ATM is usually rearranged in T-cell prolymphocytic leukaemia